<DOC>
	<DOCNO>NCT03090464</DOCNO>
	<brief_summary>Type 2 diabetes mellitus complex , chronic disease require comprehensive treatment plan aim meeting multitude therapeutic target associate micro- macro-vascular risk reduction . There evidence patient support various form significant positive impact adherence treatment meet target patient type 2 diabetes mellitus . The purpose study evaluate use digital disease management tool ( Smart phone- web portal-based tool ) , addition Standard Care T2DM , improve glycemic control . Other variable important T2DM ( weight , blood pressure , lipid level ) , also evaluate along patient-reported outcome , satisfaction treatment adherence antihyperglycemic treatment . Study duration 6 month .</brief_summary>
	<brief_title>A 6-month Clinical Study Evaluate Effect Digital Disease Management Tool Patients With T2DM</brief_title>
	<detailed_description>Type 2 diabetes mellitus ( T2DM ) complex , chronic disease require comprehensive treatment plan aim meeting multitude therapeutic target associate micro- macro-vascular risk reduction . There evidence patient support various form significant positive impact adherence treatment meet target patient type 2 diabetes mellitus . A digital disease-management tool , smart phone- web-based portal , develop incorporates follow feature aim improve patient population outcome : Treatment management help patient remember take medication track adherence ; Goal setting , include medical nutrition therapy , appropriately prescribed physical activity , weight loss patient overweight obese ; Tracking data collection blood glucose , weight , exercise , enter patient automatically activity via Bluetooth pedometer activity tracker ; Assessments capture patient belief order tailor personalize content individual need ; educational motivational content form short message , text , video cover T2DM treatment , lifestyle advice ; Web portal display collect data back patient healthcare practitioner real-time allow well timely management diabetes . This tool add Standard Care T2DM . Data collect patient utilize tool , compare . Clinical assessment part Standard Care collect , well standard Patient Reported Outcomes disease . Glycemic control consider goal T2DM disease management plan .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Provision write informed consent ; Diagnosed T2DM ; Male female age &gt; /= 18 year time consent ; Treatment 1 noninsulin antihyperglycemic medication least 6 month prior enrollment ; Own access smart phone internet access access internet via tablet personal computer least day ; HbA1c level must obtain enrollment visit 14 day prior Visit 1 must &gt; /=7.5 % &lt; /=11.0 % . Most hbA1c value obtain within past 9 month must also within range ; Body mass index &gt; /= 25 &lt; /=55 kg/mm2 within last 3 month ; Ability communicate English ; Judged primary care physician suitable hearing , vision , manual dexterity , ability understand instruction , ability use understand smart phone internet application ; Negative pregnancy test female subject childbearing potential . Pregnancy ; Insulin use baseline ; Current use smart phone web portalbased tool design help management T2DM ; History Type 1 diabetes ketoacidosis ; Currently take weight loss medication ; Involvement plan and/or conduct study ; Previous enrollment present study ; Participation clinical study investigational product disease state management program last 30 day ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Digital disease management</keyword>
	<keyword>T2DM</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Diabetes mellitus</keyword>
</DOC>